Abstract A His-tagged derivative of the multidrug e¥ux pump AcrB could be crystallized in three di¡erent space groups (R3, R32 and P321). Experimental MAD-phasing maps from R32 AcrB His crystals were obtained to a resolution of 3.5 A î . Datasets of native and substrate soaked AcrB His crystals were collected at the Swiss Light Source X06SA beamline up to a resolution of 2.7 A î and re¢nement of these data provided good quality electron density maps, which allowed us to complement the published AcrB structure (PDB code 1iwg). Introduction of amino acids 860^865 and 868 lacking in the 1iwg structure and deletion of a highly disordered region (amino acids 669^678) improved R free and average B factors in the 2.7 A î model. We could not identify signi¢cant densities indicating speci¢c antibiotic binding sites in the AcrB R32 space group datasets under the soaking conditions tested. ß
Introduction
Bacteria have evolved three general mechanisms of resistance towards antibiotics: (i) resistance by target modi¢ca-tion; (ii) resistance by antibiotic modi¢cation; and (iii) resistance through the action of antibiotic e¥ux pumps. Membrane protein pumps responsible for the latter type of resistance can be classi¢ed as (i) ABC-type antibiotic resistance pumps, which utilize the free energy of adenosine triphosphate (ATP) hydrolysis to energize the e¥ux of toxic compounds over the membrane or (ii) secondary antibiotic e¥ux pumps which use the electrochemical gradient of ions across the membrane in an antiport modus to energize e¥ux processes.
Secondary antibiotic/multiple drug resistance transporters can be divided into four families [1, 2] : (i) major facilitator superfamily (MFS); (ii) small multidrug resistance family (SMR); (iii) multidrug and toxic compound extrusion family (MATE); and (iv) resistance nodulation cell division superfamily (RND, TC# 2.A.6). Members of the RND superfamily involved in the transport of antibiotics belong to the family of the (largely Gram-negative bacterial) hydrophobe/amphiphile e¥ux-1 (HAE1) family (TC# 2.A.6.2). The proton motive force-driven RND/HAE1 drug/H þ antiporters usually function within a tripartite system including an outer membrane channel (outer membrane factor family (OMF, TC# 1.B.17)) and a member of the membrane fusion protein family (MFP, TC# 8.A.1) (Fig. 1) . The drug e¥ux is believed to occur via the initial binding of the drug to the RND component and subsequent transport through the OMF. The role of the MFP is still puzzling, although it has been shown that it is absolutely essential for the function of the whole pump [3^5] . Besides the well-studied RND^MFP^OMF systems in Pseudomonas aeruginosa (e.g. MexAB-OprM and MexCD-OprJ) [6] , the AcrAB^TolC tripartite system is currently the most studied due to the structural information on the AcrB and TolC components [7^9] . The substrate speci¢city of the AcrAB^TolC system is rather broad: anionic, cationic and zwitterionic as well as neutral compounds are transported, including £uoroquinolones, macrolides and phenylpropanoids. Most of the substrates are hydrophobic and can traverse the inner membrane. A notable exception are the L-lactams transported by the system [10] . TolC has been structurally characterized to a resolution of 2.1 A î by crystallographic means [9] . Apart from the membrane-embedded regions (about 4 nm thickness), a TolC trimer has a 10 nm periplasmic barrel domain composed of 12 K-helices, which form a long conduit through which the drugs might be transported. The crystallization and structural analysis of AcrB have been described recently [8, 11] . Like TolC, AcrB forms a homotrimer, which is believed to be its functional unit. Each AcrB monomer contains 12 membrane spanning K-helices and a large periplasmic domain ( Fig. 2A) . The transmembrane Khelices in the AcrB trimer are organized in a way that these encircle a 35 A î wide cavity, which is believed to be ¢lled with phospholipids in vivo (Fig. 2B) . Within each monomer, transmembrane helices 4 and 10, encircled by the other transmembrane helices of the monomer, harbor the residues Lys940 (helix 10) and Asp407 and 408 (helix 4), which are postulated to be important for the H þ translocation (Fig. 2B and [8] ). The periplasmic domain can be divided into two major parts: the TolC docking domain and the pore domain. The TolC docking domain exhibits a funnel-like structure narrowing to the central pore located in the pore domain. The internal diameter on the top of the funnel is about the same as the diameter of the TolC periplasmic conduit. The central pore structure consists of three K-helices, one donated by each AcrB monomer (Fig. 2C) . Another remarkable feature is a long loop protruding from one monomer through the neighboring monomer. These loops appear to make the main and almost only interaction between the monomers. At the prox-imal end of the central pore, the structure opens up to a central cavity, leading to the cavity in the transmembrane part. Moreover, three entrances or vestibules reaching towards the central cavity are located just above the membrane plane. From the AcrB native structure a drug transport model has been postulated [8, 12] which involves the transport of membrane permeable drugs from the inner lea£et of the cytoplasmic membrane through a groove formed by transmembrane helices 8 and 9 towards the central cavity. L-Lactam antibiotics are believed to enter the central cavity via the vestibules. Once in the central cavity, the substrates are believed to be transported into the external medium through the central pore (which has to open ¢rst), through the funnel part of the AcrB periplasmic domain and ¢nally through TolC. Currently, the elucidation of the molecular mechanism(s) of transport of the wide variety of substrates is a major challenge. The substrate binding and speci¢city has already been addressed by structural and functional studies. It has been shown that the periplasmic part of the RND component is responsible for the substrate speci¢city of the whole tripartite system. This has been demonstrated for AcrB, MexB, MexD, and MexY [13^15] . Additionally, structural analysis of binding of antibiotics to AcrB (based on 3.5^3.8 A î data) has been reported recently [7] . Binding of four AcrB substrates, rhodamine G6, ethidium, dequalinium and cipro£oxacin is observed in the central cavity. For all substrates except cipro£oxacin, Phe386 (helix 3) was one of the main hydrophobic contacts, in fact in the case of ethidium it seemed to be the only one. For dequalinium, only the top quinolinium moiety was close to the charged residues Asp99 and 101 but the bottom quinolinium moiety was close to only Phe386. For cipro£oxacin, Phe458 and 459 (helix 5) were the main ligands. Binding of three substrate molecules per trimer was observed as enforced by the three-fold symmetry of the R32 space group. Another observation was an 1 ‡ outward tilting of the periplasmic domain, postulated to be induced by the substrate binding [7] .
We report here on the crystallographic analysis of di¡rac-tion data obtained (up to 2.7 A î ) with crystals from native AcrB His , a selenomethionine (SeMet) substituted derivative and substrate soaked derivatives of AcrB His .
Materials and methods

Crystal optimization and SeMet substitution
Expression of acrB His , preparation of membranes, puri¢cation and initial crystallization of AcrB His are described in Pos and Diederichs [11] . To obtain SeMet substituted AcrB, Escherichia coli C43(DE3)/ Fig. 1 . Hypothetical structure of tripartite e¥ux pumps in Gram-negative bacteria, e.g. the AcrAB^TolC e¥ux pump from E. coli (adapted from Nikaido and Zgurskaya [10] ).
pET24acrB His was grown in methionine deprived minimal media including SeMet. Yields were 6 mg of SeMet substituted AcrB His from 1 l of minimal media culture. SeMet crystals (200U200U100 Wm 3 ) were grown using 0.1 M Na-HEPES, pH 7.5, 10^60 mM NaCl and 8% (w/v) PEG 4000 as precipitant and protein at 39 mg/ml in a hanging drop (1:1 dilution) experimental setup over a 0.5 ml precipitant solution in the reservoir. Crystals which belong to the space group R32 were frozen in liquid ethane using glycerol as cryoprotectant. AcrB His R3 crystals were obtained using 17 mg/ml protein diluted 1:1 in 0.1 M Na-HEPES, pH 7.5, 50 mM NaCl, 5% (v/v) glycerol and 5% (w/v) PEG 4000 as precipitant in a hanging drop experimental setup over a 0.5 ml precipitant solution in the reservoir. P321 crystals (about 100U100U10 Wm 3 ) were obtained using 70 mM Na-citrate, pH 4.6, 8% (v/v) glycerol and 16% (v/v) PEG 400 as precipitant (1:1 dilution, hanging drop). For freezing these crystals, solid glucose was added to the droplet containing the crystal and allowed to saturate the drop in a stepwise manner. Large single native AcrB His (R32) crystals with dimensions up to 1000U800U400 Wm
(at 1% (w/v), 2.5, 3.2 and 9 mM ¢nal concentration, respectively). AcrB His was used at 16.8 mg/ml. Crystals were transferred in 11 steps to 0.1 M Na-HEPES, pH 7.5, 5% (w/v) PEG 4000, 0.1 M NaCl and 0.05% (w/v) cyclohexyl-n-hexyl-L-D-maltoside (CHM) solutions containing 2^30% (v/v) glycerol in 5^10 min intervals. After the ¢nal soaking step at 30% (v/v) glycerol, the crystals were directly frozen into liquid propane or ethane and stored in liquid nitrogen. In soaking experiments, crystals were treated using the same procedure in the presence of 0.5^5 mM bile salt or antibiotic.
X-ray di¡raction dataset analysis and re¢nement procedure
Datasets from native crystals and heavy atom derivatives were collected at the DESY, Hamburg, Germany, EMBL beamlines BW7A, BW7B and X11. Native and substrate co-crystals as well as the MAD data were measured either at beamline X06SA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland) or at beamline ID29 of the ESRF (Grenoble, France). Data reduction was done with the XDS Software package [16] . The SeMet substructure of the SeMet derivative crystals was solved with SHELXD [17] . A total of 35 selenium sites out of 42 theoretically possible sites could be detected. Further re¢nement of the heavy atom positions was carried out with the program SHARP [18] . Solvent £attening with RESOLVE [19, 20] resulted in interpretable maps at a resolution of 3.5 A î . The structures in the other space groups were solved by molecular replacement using MOLREP [21] . As search models 1iwg and a modi¢ed version of 1iwg (model2, see Section 3) were used. All structures were re¢ned with the program REFMAC5 [22] starting with 20 cycles of rigid body re¢nement with four rigid domains consisting of residues (i) 1^30 and 334^530, (ii) 31^333, (iii) 561^859 and (iv) 531^560 and 860^1031, followed by 20 cycles of restrained re¢nement. Model building was done using the program 'O' [23] . Fig. 2 was created using Pymol (www.pymol.org) and Figs. 3 and 4 were created using DINO (www.dino3d.org).
Results and discussion
Di¡raction quality of AcrB His crystals
The ¢rst crystals of AcrB His in space group R32 were obtained in a screening procedure using the MembFac screen of Hampton (solution 30) and were rather sensitive to radiation damage [11] . The initial cryoprotection procedures led to cracking of larger crystals while freezing them in liquid nitrogen. These problems could be overcome by the optimization of the crystallization conditions and freezing protocol. Crystals grown in the presence of n-nonyl-L-D-thiomaltoside and noctyl-L-D-thiomaltoside were transferred into cryoprotection solutions containing 1 mM erythromycin or novobiocin, respectively, in the case of substrate binding studies. After the ¢nal soaking step, the crystals were directly frozen in liquid propane or ethane and stored in liquid nitrogen. This proce- Fig. 3 . Stereo view displaying the region 860^868 with (A) the F o 3F c map at 2.7 A î contoured at 3c in red and (B) 2F o 3F c electron density map at 2.7 A î contoured at 1c in blue. Shown in bold sticks from top to bottom are the residues Trp859 and the amended residues Thr860, Gly861, Met862, Ser863, Tyr864, Gln865, Leu868 and Ser869.
dure improved the di¡raction of the crystals to a resolution of 2.7 and 2.8 A î , for the native and substrate soaked crystals, respectively.
AcrB could be crystallized in two other space groups, R3 and P321. R3 crystals were obtained using the same crystallization conditions as described for R32 crystals, but with addition of 5% (v/v) glycerol in the mother liquor and 2.5% (v/v) glycerol in the initial protein droplet condition. These crystals (350U350U300 Wm 3 ) di¡racted to 3.0 A î resolution. P321 crystals (about 100U100U10 Wm 3 ) were obtained using 70 mM Na-citrate, pH 4.6, 8% glycerol and 16% (v/v) PEG 400 as precipitant. These crystals were frozen using glucose as cryoprotectant. One dataset has been collected to a resolution of 3.5 A î .
Structure solution and re¢nement
In order to obtain phase information, R32 crystals were soaked with various heavy atom compounds. Despite good datasets (to 3.0 A î resolution), phases could not be determined due to severe non-isomorphism. Especially the c-axis of the crystal unit cell varied drastically (between 490 and 520 A î ), which made direct comparison of the datasets impossible. We therefore produced crystals of SeMet substituted AcrB His and collected MAD data (Table 1) . After determining phases using the programs SHELXD, SHARP and RESOLVE, interpretable electron density maps were obtained at 3.5 A î resolution. During the process of model building, Murakami et al. [8] published a structure of AcrB based on 3.5 A î di¡raction data. Their model (PDB database entry 1iwg) was used in the initial re¢nement procedures with our di¡raction data.
The re¢nement statistics listed in Table 2 clearly demonstrate that our experimental data from native and substrate soaked crystals produced models of AcrB with high R free values after rigid body and restrained re¢nement. The highest R free values were observed with data from a R32 crystal soaked with taurocholate (m215, 3.1 A î , R free = 42.6%) and with the native R3 crystal dataset (m1, 3.0 A î , R free = 41.8%). The best R free values were obtained with the native crystal dataset m237 (3.0 A î , R free = 36.2%) and the data from the novobiocin soaked crystal m228 (2.8 A î , R free = 35.8%). In comparison, the 1iwg structure published by Murakami et al. [8] yielded an R free value of 35.5% (at 3.5 A î ) and the unliganded structure 1oy6 published by Yu et al. [7] showed an R free of 33.0% at 3.7 A î . The average B factors from the re¢ned structures based on 1iwg are in almost all cases above 100 A î 2 , with the notable exception of the m1 3.0 A î dataset in R3 (61.6 A î 2 ). High average B factors were also found for the structures 1iwg [8] and 1oye [7] . Due to disorder, the 1iwg AcrB model lacks regions 1^6, 499^512, 860^868 and 1037^1049 [8] . Inspection of our F o 3F c and 2F o 3F c maps obtained with datasets m1, m209, m227 and m228 (Table 2 ) revealed the presence of interpretable density in the region of residues 860^868 (Fig. 3a and b) . We amended the model in this region by implementing amino acid residues 860^865 and 868. Furthermore, we corrected the side chain location of Glu112 (pore region) and His596 and deleted amino acids 669^678 due to poor electron density. The modi¢ed model (designated model2) resulted in slightly better R free factors in the re¢nement cycle compared to the same re¢nement done with 1iwg ( Table 2 ). The best R free factor was obtained with the datasets from native R32 crystals using this modi¢ed model. Re¢nement against data from crystal m237 yielded an R factor of 32.9% and R free of 35.0%. The electron density in the omitted region 669^678 after re¢ne-ment with model2 is di⁄cult to interpret and requires further analysis before an alternate chain progression can be determined. Remarkably, the B factors dropped approximately 10^30% compared to the re¢ned 1iwg structure (Table 2 ).
Substrate binding studies
We have tested several compounds (erythromycin, novobiocin, taurocholate, taurodeoxycholate, lome£oxacin, cipro£ox-acin, deoxycholate, chloramphenicol and Hoechst 33342) for binding to AcrB His by crystal soaking experiments and occasionally by co-crystallization. All data obtained from compound soaked crystals resulted in higher R factors, with the exception of m228 (novobiocin soak, R free = 35.8% with 1iwg and 36.8% with model2). Very high R factors were obtained with the lome£oxacin and erythromycin soaked crystal datasets m222 and m227 ( = 40%). In comparison, Yu et al. [7] reported almost equal R free factors for the unliganded and liganded structures (32^34%) at 3.5^3.8 A î . Our experimental setup di¡ers from that described in Yu et al. [7] by (i) the presence of a His-tag at the C-terminus of the protein, (ii) a higher pH of the soaking bu¡er (7.5 versus 5.6 and 6.6) and (iii) the use of CHM (0.05%) rather than dodecyl-L-D-maltoside (DDM) (0.1%) as detergent. Furthermore, in the determination of drug binding sites, Yu et al. [7] used electron density omit maps directly after data scaling and molecular replacement, before doing any re¢nement. We calculated the F o 3F c and 2F o 3F c maps (Fig. 4) after molecular replacement and re¢nement (rigid body and restrained re¢nement with REFMAC5). Inspection of F o 3F c di¡erence maps using our substrate soaked crystal datasets did not reveal any signi¢cant positive density features di¡erent from the ones observed with the native datasets (Fig. 4) . The 2F o 3F c maps of m209 (native), m227 (erythromycin soaked crystal) and m228 (novobiocin soaked crystal) at 2.7^2.8 A î all showed similar density features (not shown). Despite the good resolution of the density maps (2.8 A î ), we were not able to identify di¡erence density features that could be attributed to bound ligands. A possible reason for this is the low quality of the phases derived from a high R factor model. We expect that a future improvement of the AcrB model (with lower R free ) might lead to the unambiguous identi¢cation of substrate binding sites, allowing a deeper understanding of the functional aspects of AcrB.
